What is WeGovy?

Posted on May 5, 2023 by Sally-Anne Turner

With all the recent chatter online and in the news about WeGovy and its incredible results, it's no wonder people looking to shed weight are interested in hearing about what Wegovy actually is. Social media platforms are filled with transformation stories, celebrities are openly discussing their use of weight loss medications, and healthcare professionals are increasingly recognising the role of medical interventions in treating obesity as a chronic health condition. Here at Bodyline Wellness Clinics, we're happy to assist in offering the latest and greatest in medical weight loss information and guidance, so buckle up as you find out: what is Wegovy?

The landscape of weight management has undergone a revolutionary transformation in recent years, with medications like WeGovy representing a significant breakthrough in how we approach obesity treatment. For decades, people struggling with their weight have been told that willpower and discipline are all they need, but we now understand that obesity is far more complex than simple lifestyle choices. It involves hormonal regulation, metabolic processes, genetic factors, and neurological pathways that control hunger and satiety. Wegovy works by addressing some of these underlying biological mechanisms, offering hope to individuals who have tried traditional diet and exercise approaches without achieving lasting results.

At Bodyline Clinic, we've supported over 100,000 patients across the UK throughout their weight loss journeys over the past 18 years. Our experienced clinical team understands that every patient's situation is unique, which is why we offer personalised medical weight loss programmes that combine prescription medications with comprehensive lifestyle support, nutritional guidance, and ongoing clinical monitoring. Whether you're based in our clinic locations across the Northwest of England or accessing our services through online consultations available UK-wide, our specialist weight loss nurses are here to help you understand your options and develop a treatment plan tailored to your individual needs and health goals.

Wegovy or Ozempic?

Wegovy and Ozempic are both medications used in the treatment of type 2 diabetes. They both contain the active ingredient semaglutide, which belongs to a class of drugs called GLP-1 receptor agonists. GLP-1 receptor agonists work by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1) in the body. This naturally occurring hormone is produced in your intestines after you eat, and it plays several crucial roles in regulating your appetite, blood sugar levels, and digestive processes.

Understanding the difference between Wegovy and Ozempic can be confusing, especially with so much information circulating online and conflicting reports in the media. The fundamental truth is that both medications contain exactly the same active ingredient – semaglutide – but they've been approved for different primary purposes and are available in different dosage strengths. Think of it like this: the same medication has been studied, tested, and approved for two different but related health conditions, with the dosing and branding adjusted accordingly.

Wegovy is a once-weekly injection. It is manufactured by Novo Nordisk in the US, the same pharmaceutical company that produces Ozempic, also an injection administered once a week. Wegovy has essentially been remarketed as a weight loss solution for obesity as opposed to type 2 diabetes. The distinction is important because it reflects the rigorous clinical trial process that these medications undergo. Ozempic was initially approved for managing type 2 diabetes, but during clinical trials, researchers observed significant weight loss in patients taking the medication. This led to additional studies specifically examining semaglutide's effectiveness for weight management in people with obesity, which ultimately resulted in the approval of Wegovy as a dedicated weight loss medication.

Both medications have been seen to reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with obesity and/or type 2 diabetes. This cardiovascular benefit is particularly significant because obesity and type 2 diabetes are both major risk factors for heart disease. The ability of semaglutide to address multiple health concerns simultaneously – blood sugar control, weight management, and cardiovascular risk reduction – makes it a particularly valuable tool in treating metabolic health conditions. For many patients, this means not just losing weight but also improving their overall health markers and reducing their long-term risk of serious health complications.

However, the incredible result that comes alongside these health benefits is a health transformation and drastic weight loss. Studies have shown that users of Ozempic/Wegovy saw an average loss of 15% of their overall body weight! This medication has helped people with BMIs listed under obese to reach healthy BMIs, even if they've spent years trying beforehand. To put this in perspective, if someone weighs 100 kilograms at the start of treatment, a 15% weight loss would mean losing 15 kilograms – a substantial and potentially life-changing amount of weight for many individuals.

The clinical trial results have consistently demonstrated that semaglutide produces weight loss outcomes that surpass what most people can achieve through lifestyle changes alone. While diet and exercise remain important components of any weight management strategy, the addition of medication like Wegovy or Ozempic can make the difference between struggling to lose a few pounds that quickly return and achieving meaningful, sustained weight loss that improves quality of life and reduces health risks. Many patients report that the medication helps them feel fuller sooner, reduces constant food thoughts and cravings, and makes it significantly easier to stick to healthier eating patterns without feeling deprived or constantly hungry.

Ozempic is offered as an aid to help people suffering from obesity with a healthy diet and exercise regime, as well as to improve glycaemic control in those suffering from diabetes. It is also approved to reduce the risk of major adverse cardiovascular events. The medication works best when integrated into a comprehensive treatment programme that addresses all aspects of weight management. At Bodyline Clinic, we don't simply prescribe medication and send patients on their way. Our approach involves regular monitoring, nutritional counselling, lifestyle guidance, and ongoing support from our specialist weight loss nurses who understand the challenges of managing weight and can provide practical strategies for long-term success.

The key difference in dosing between Wegovy and Ozempic reflects their different primary indications. Wegovy is available in higher maximum doses specifically calibrated for weight loss, while Ozempic dosing is optimised for diabetes management. However, both medications follow a gradual dose escalation schedule, starting with a lower dose and slowly increasing over several weeks. This titration approach helps minimise side effects and allows your body to adjust to the medication gradually. Common side effects, particularly in the early weeks of treatment, can include nausea, digestive changes, and reduced appetite – which is actually part of how the medication works to promote weight loss.

How does Wegovy work?

Both Wegovy and Ozempic work by stimulating the release of insulin from the pancreas in response to meals, reducing the amount of glucose produced by the liver, and slowing down the emptying of food from the stomach. This helps to lower blood sugar levels and improve glycaemic control in people with type 2 diabetes. But the mechanisms of action extend beyond these basic functions, involving complex interactions with multiple systems in your body that regulate hunger, satiety, energy expenditure, and metabolism.

To truly understand how Wegovy works, it helps to know more about the GLP-1 hormone that semaglutide mimics. When you eat a meal, your intestines release natural GLP-1, which serves as a signal to your body that food has arrived and various processes need to be activated. This hormone travels through your bloodstream and interacts with GLP-1 receptors located in numerous organs and tissues, including your pancreas, stomach, liver, brain, and even your heart. Each of these interactions contributes to the overall effect of the medication on your weight and metabolic health.

In your brain, GLP-1 receptors are found in areas that control appetite and food intake. When semaglutide activates these receptors, it reduces hunger signals and increases feelings of fullness and satisfaction. Many patients describe this as finally feeling "normal" around food – not constantly thinking about their next meal, not experiencing overwhelming cravings, and feeling satisfied with smaller portions. This isn't willpower or discipline; it's a biological change in how your brain processes hunger and satiety signals. The medication essentially helps restore more normal appetite regulation in people whose hunger signals may have become dysregulated due to obesity, insulin resistance, or other metabolic factors.

In addition to their glucose-lowering effects, both Wegovy and Ozempic have been shown to promote weight loss. This is believed to be due to their ability to reduce appetite and food intake, as well as their effects on the metabolism. The delayed gastric emptying – meaning food stays in your stomach longer – contributes significantly to the feeling of fullness that persists for hours after eating. When your stomach empties more slowly, you don't experience the rapid return of hunger that often occurs an hour or two after a meal when following traditional calorie-restricted diets. This sustained satiety makes it much easier to maintain a calorie deficit without feeling constantly hungry or deprived.

The metabolic effects of semaglutide extend beyond simple appetite suppression. Research suggests that GLP-1 receptor agonists may influence how your body processes and stores energy, potentially favouring fat burning over fat storage. While the medication doesn't directly "burn fat" in the way some supplements claim to, it creates conditions in your body that make it easier to lose weight and harder to regain it. The combination of reduced calorie intake due to decreased appetite, improved insulin sensitivity, better blood sugar control, and potential metabolic advantages creates a synergistic effect that produces the impressive weight loss results seen in clinical trials.

Another important aspect of how Wegovy works relates to food reward and cravings. Many people struggling with obesity report intense cravings for specific foods, particularly those high in sugar, fat, or salt. These cravings aren't simply a matter of weak willpower – they involve complex neurological pathways related to dopamine and the brain's reward system. Semaglutide appears to modulate these reward pathways, with many patients reporting that foods they once craved intensely simply don't hold the same appeal anymore. This reduction in food-related reward seeking can be incredibly liberating for people who have spent years feeling controlled by their cravings and unable to resist certain foods despite their best intentions.

At Bodyline Clinic, our weight loss injection programmes incorporate these medications as part of a comprehensive approach to weight management. We understand that while the medication provides powerful biological support for weight loss, lasting success also requires addressing behavioural patterns, developing healthier eating habits, increasing physical activity, and building sustainable lifestyle changes that can be maintained long-term. Our specialist nurses work with each patient to develop personalised strategies that maximise the benefits of the medication while establishing habits that support continued weight management even after treatment ends.

Is Wegovy available in the UK?

It's worth noting that while Wegovy and Ozempic share many similarities, there are some key differences between the two medications. For example, Wegovy is a higher-dose formulation of semaglutide compared to Ozempic. Wegovy as a brand is higher in price and is not currently available to people in the UK. The availability situation has been complicated by supply issues, high demand, and regulatory considerations. While Wegovy has been approved in the UK, accessing it through NHS prescriptions remains limited, and private availability has been inconsistent due to manufacturing and distribution challenges.

The supply situation for weight loss medications has been a significant challenge globally, not just in the UK. The unprecedented demand for these medications, driven by their effectiveness and increased public awareness, has at times outstripped manufacturing capacity. Pharmaceutical companies have been working to increase production, but scaling up manufacturing of complex biological medications takes time and substantial investment in facilities and quality control processes. This has led to allocation systems where available supplies are prioritised for certain patient groups or distributed across different markets in carefully managed quantities.

Luckily, here at Bodyline we are excited to offer the game changing Ozempic Slimming Pen as part of our medical weight loss programmes! Wegovy will be available shortly. This allows clients to make use of Wegovy's incredible weight loss results here in the UK and reach their goal weight quickly and safely. Our clinical team stays informed about medication availability and regulatory updates, ensuring that we can offer the most effective treatment options to our patients as they become available. We work with reputable UK-based suppliers and pharmacies to ensure that all medications we prescribe are genuine, properly stored, and meet the highest quality standards.

The regulatory landscape for weight loss medications in the UK is overseen by the Medicines and Healthcare products Regulatory Agency (MHRA), which ensures that medications meet strict safety and efficacy standards before they can be prescribed. Both Ozempic and Wegovy have been approved by the MHRA, but their availability through different prescribing routes varies. NHS England has specific guidelines about when these medications can be prescribed on the NHS, typically requiring patients to meet certain BMI thresholds and have weight-related health conditions. These restrictions are partly due to cost considerations and the need to prioritise limited supplies for patients with the greatest clinical need.

For patients seeking private treatment, the situation offers more flexibility. Private clinics like Bodyline can prescribe these medications to eligible patients who meet clinical criteria, even if they wouldn't qualify for NHS treatment. This is particularly important for people who are significantly overweight but may not yet have developed the serious health complications that would make them eligible for NHS prescribing. Early intervention with effective weight loss treatment can actually prevent the development of conditions like type 2 diabetes, high blood pressure, and cardiovascular disease, making private access to these medications a valuable option for many individuals.

The cost of private treatment is an important consideration for many patients. While weight loss injections represent a significant investment, it's worth considering the long-term costs of obesity-related health conditions, including medications for diabetes, blood pressure, and cholesterol, as well as the potential need for more intensive medical interventions down the line. Many patients find that the investment in effective weight loss treatment pays dividends in improved health, reduced need for other medications, and enhanced quality of life. At Bodyline Clinic, we offer various treatment options at different price points, and our team can discuss the costs and benefits of different approaches during your initial consultation.

It's also important to understand that eligibility for these medications isn't simply about wanting to lose weight. Medical professionals must assess whether the treatment is appropriate and safe for each individual patient. This involves reviewing your medical history, current medications, existing health conditions, and weight-related health risks. Certain medical conditions may make GLP-1 medications unsuitable, and some medications may interact with semaglutide in ways that require careful management. This is why accessing these treatments through a regulated clinic with experienced medical professionals is so important – it ensures that the medication is prescribed safely and appropriately for your specific situation.

Where can I buy Wegovy?

There will be lots of websites online that will be trying to sell medication called Wegovy in the UK, but please note that these online pharmacies may not be regulated or safe. The internet has unfortunately become a marketplace for counterfeit and illegally supplied medications, and weight loss injections are particularly targeted by unscrupulous sellers looking to profit from high demand. These fake medications may contain incorrect amounts of active ingredient, be contaminated with harmful substances, or be completely counterfeit products that contain no semaglutide at all. Using such products puts your health at serious risk and offers no guarantee of effectiveness.

The dangers of unregulated online pharmacies extend beyond counterfeit medications. Even if the medication itself is genuine, purchasing it without proper medical supervision means you miss out on crucial safety checks, monitoring, and support. Weight loss injections can cause side effects that need to be managed, and they may not be appropriate for people with certain health conditions. Without a proper medical assessment, you could be putting yourself at risk of serious complications. Additionally, using these medications without professional guidance means you're less likely to achieve optimal results, as you won't receive the nutritional counselling, lifestyle advice, and ongoing support that maximises the effectiveness of treatment.

At Bodyline Wellness Clinics, we source our Ozempic Slimming Pen from safe and secure UK laboratories, and we are regulated by the CQC – the same people who regulate the NHS hospitals and general practices. This regulation means that our clinics must meet rigorous standards for safety, clinical governance, staff training, medication storage and handling, patient care, and record keeping. Regular inspections ensure that we maintain these standards consistently, giving you confidence that you're receiving care from a legitimate, professional healthcare provider. You can verify our CQC registration and read our inspection reports on the CQC website, providing complete transparency about the quality of care we deliver.

Our CQC regulation sets us apart from many online providers and beauty salons that have begun offering weight loss injections without appropriate medical oversight. We have qualified doctors and nurse prescribers who conduct thorough assessments before prescribing any medication, ensuring that treatment is safe and appropriate for each individual patient. Our clinics are equipped to handle medical emergencies, our staff receive regular training on the medications we prescribe, and we maintain comprehensive medical records that ensure continuity of care throughout your treatment journey. This level of professional healthcare provision is essential when using powerful prescription medications that can have significant effects on your body.

Over 100,000 people have come to us and used our expertise and experience to help them in their weight loss journeys. You can too! If you're interested in making use of Wegovy's active ingredient in your goal to a healthier you, call us today on 0800 995 6036 or fill in our online contact form for a call back. Our friendly customer service team can answer your initial questions, explain how our programmes work, discuss costs and payment options, and book you in for an initial consultation either at one of our clinic locations or via online video consultation if you're located elsewhere in the UK.

The consultation process at Bodyline is designed to be thorough yet comfortable. During your initial appointment, one of our specialist weight loss nurses will take a comprehensive medical history, discuss your weight loss goals and previous attempts at losing weight, explain how the medications work and what you can expect, assess your eligibility for treatment, and develop a personalised treatment plan tailored to your needs. This isn't a rushed, transactional interaction – it's a genuine healthcare consultation where you have the opportunity to ask questions, express concerns, and ensure you feel fully informed and comfortable before starting treatment.

We have clinic locations across the Northwest of England, including Birkenhead, Liverpool, Manchester, St Helens, Stockport, Stoke-on-Trent, and Warrington, making it convenient for patients throughout the region to access our services. Each clinic offers the same high standard of care, with experienced staff, comfortable consultation rooms, and a welcoming environment where you can feel at ease discussing your weight and health concerns. For patients located elsewhere in the UK, our online consultation service provides access to the same expert care and treatment options, with medications delivered securely to your home and ongoing support provided via video consultations and our patient support systems.

You can see the same results as American Wegovy users, just in time for summer! But it's important to set realistic expectations about the timeline for weight loss. While some patients notice reduced appetite and begin losing weight within the first few weeks of treatment, significant weight loss typically occurs over several months. The medications work gradually, and the dose is increased slowly over time to minimise side effects and allow your body to adjust. Most clinical trials evaluate results over 68 weeks (approximately 16 months), which is the timeframe in which the average 15% weight loss is achieved. This isn't a quick fix – it's a medical treatment that requires commitment and patience, but the results can be truly transformative for people who have struggled with their weight for years.

Beyond the weight loss itself, many patients report improvements in numerous aspects of their health and wellbeing. Blood pressure often decreases, blood sugar control improves, cholesterol levels may normalise, joint pain reduces as there's less weight bearing down on knees and hips, sleep quality improves (particularly if sleep apnoea was an issue), energy levels increase, and mobility and fitness improve. Many patients also report psychological benefits, including improved self-esteem, reduced anxiety about their weight, better mood, and increased confidence in social situations. These holistic improvements in health and quality of life are often just as important as the number on the scales, and they reinforce the value of effective weight loss treatment.

It's also worth noting that weight loss medications like Wegovy and Ozempic are not cosmetic treatments for people who simply want to lose a few pounds for aesthetic reasons. These are serious medical interventions for people with obesity or significant overweight with related health conditions. Prescribing guidelines exist to ensure these powerful medications are used appropriately for people who will benefit most from them. At Bodyline, our clinical team carefully assesses each patient's eligibility based on their BMI, health conditions, medical history, and individual circumstances. We follow evidence-based prescribing guidelines and prioritise patient safety above all else.

The future of weight loss medication looks promising, with ongoing research into new formulations, different delivery methods (including oral versions of GLP-1 medications), and combination therapies that may prove even more effective. Pharmaceutical companies are investing heavily in this field, recognising the enormous unmet need for effective obesity treatments. At Bodyline, we stay at the forefront of these developments, continuously evaluating new treatment options and updating our programmes to incorporate the latest evidence-based approaches. Our commitment to ongoing professional development ensures that our clinical team remains expert in the latest weight management strategies and can offer patients the most effective treatments available.

If you're considering weight loss medication, now is an excellent time to explore your options. The evidence base for GLP-1 medications is robust, the safety profile is well-established, and the potential benefits for people struggling with obesity are significant. Don't let another year pass feeling unhappy with your weight and frustrated by failed diet attempts. Book a consultation at Bodyline Clinic to discuss whether weight loss injections could be the right solution for you. Our experienced team is here to support you every step of the way, from initial assessment through to achieving your goal weight and maintaining your results long-term.

Taking the first step towards addressing your weight can feel daunting, but you don't have to do it alone. With over 18 years of experience, CQC regulation, and a proven track record of helping patients achieve meaningful, lasting weight loss, Bodyline Clinic offers the expertise, support, and medical treatments you need to finally achieve the results you've been seeking. Whether you're interested in Mounjaro, Saxenda, Phentermine, or other weight loss medications, our team can help you find the right treatment for your individual needs. Contact us today to start your journey towards better health, improved confidence, and a happier, healthier you.